SC 13G/A: NAYA Biosciences, Inc.
Ticker: IVF · Form: SC 13G/A · Filed: Nov 13, 2024 · CIK: 1417926
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by NAYA Biosciences, Inc..
Risk Assessment
Risk Level: low
Filing Stats: 1,034 words · 4 min read · ~3 pages · Grade level 7.6 · Accepted 2024-11-13 11:18:26
Key Financial Figures
- $0.0001 — Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class o
Filing Documents
- ea022071805-13ga2intra_naya.htm (SC 13G/A) — 51KB
- 0001213900-24-097255.txt ( ) — 53KB
Ownership
Item 4. Ownership. (a) and (b): As of the close of business on September 30, 2024, each of the Reporting Persons may have been deemed to have beneficial ownership of 184,000 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal (the “ Intracoastal Warrant ”), and all such shares of Common Stock in the aggregate represent beneficial ownership of approximately 4.5% of the Common Stock, based on (1) 3,906,072 shares of Common Stock outstanding as of August 14, 2024 , as reported by the Issuer, plus (2) 184,000 shares of Common Stock issuable upon exercise of the Intracoastal Warrant. (c) Number of shares as to which each Reporting Person has: (i) Sole power to vote or to direct the vote: 0 . (ii) Shared power to vote or to direct the vote: 184,000 . (iii) Sole power to dispose or to direct the disposition of 0 . (iv) Shared power to dispose or to direct the disposition of 184,000 .
Ownership of Five Percent or Less of a Class
Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following þ .
Certification
Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11. Page 5 of 6 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: November 13, 2024 /s/ Mitchell P. Kopin Mitchell P. Kopin /s/ Daniel B. Asher Daniel B. Asher Intracoastal Capital LLC By: /s/ Mitchell P. Kopin Mitchell P. Kopin, Manager Page 6 of 6